Products for Research Use Only
RegisterLogin

COX-2-IN-55

CAT: 0804-HY-171992-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-171992-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
COX-2-IN-55 (compound 1) is an orally active, Celecoxib -based analog with broad-spectrum anticancer activity and weak COX-2 inhibition. COX-2-IN-55 specifically inhibits SERCA2, increases caspase-3 cleavage and DR5 levels, thereby activating GRP78 and inhibiting the development of triple-negative breast cancer (TNBC). COX-2-IN-55 can also downregulate the levels of angiogenic markers VEGF-α and IL-8, inhibiting the formation of microvessels[1].
CAS Number
2649115-80-8
UNSPSC
12352005
Target
Calcium Channel; Caspase; VEGFR
Related Pathways
Apoptosis; Membrane Transporter/Ion Channel; Neuronal Signaling; Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Smiles
O=S(NC1=CC(N)=CC=C1)(C2=CC=C(N3N=C(C(F)(F)F)C=C3C4=C(C)C=CC(C)=C4)C=C2)=O
Molecular Formula
C24H21F3N4O2S
Molecular Weight
486.51
References & Citations
[1]Louie Stan, et al. Methods, compounds and compositions for the treatment of cancer by inhibiting notch-1 maturation. World Intellectual Property Organization, WO2021113605 A1. 2021-06-10.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Caspase 3; VEGFR1/Flt-1

Related Products

CatalogName
HY-101655-01COX-2-IN-2
HY-175637COX-2-IN-57
HY-174159COX-2-IN-54
HY-153762-01COX-2-IN-32
HY-145988COX-2-IN-11
HY-146198COX-2-IN-19
HY-U00275COX-2-IN-1
HY-147809COX-2-IN-20
HY-156254COX-2-IN-35
HY-161294COX-2-IN-41

Alternative Products

CatalogName
T211247-01COX-2-IN-55
311865-01Cox-2
GTR19206710-01COX-2-IN-2
BA5932-10COX-2-IN-6
T89933-01COX-2-IN-46
T89018-01COX-2-IN-44
T86083-01COX-2-IN-40
T60457-01COX-2-IN-11
T61264-01COX-2-IN-19
535019-01Cox-2 discontinued

Popular Products